RNA Therapeutics Part B
Specificaties
Gebonden, blz.
|
Engels
Elsevier Science |
e druk, 2024
ISBN13: 9780443235443
Rubricering
Onderdeel van serie
Progress in Molecular Biology and Translational Science
Levertijd ongeveer 8 werkdagen
Samenvatting
RNA Therapeutics, Part B, Volume 204 updates on a new class of medication based on RNA molecules, with chapters on a variety of topics, including RNA therapeutics for cardiovascular disorders, RNA therapeutics for kidney injury, RNA therapeutics for beta-thalassemia, RNA therapeutics for infectious diseases, RNA therapeutics for reproductive diseases, Potential of RNA and transcriptomic data to drive drug repurposing for various diseases, RNA therapeutics for glioma/glioblastoma, RNA therapeutics for regenerative medicine, Advances in the liposome-based delivery systems for RNA therapeutics in cancer, Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics in cancer, and more.
Specificaties
Inhoudsopgave
Preface<br>Dinh -Toi Chu and Van Thai Than<br>1. RNA therapeutics for cardiovascular disorders<br>Negin Parsamanesh<br>2. RNA therapeutics for non- alcoholic fatty liver diseases<br>Ali Mahmoudi<br>3. RNA therapeutics for kidney injury<br>Pouya Goleij<br>4. RNA therapeutics for beta-thalassemia<br>Hong Quan Duong<br>5. RNA therapeutics for infectious diseases<br>Van Thai Than<br>6. RNA therapeutics for reproductive diseases<br>Mehmet Fırat Mutlu<br>7. Potential of RNA and transcriptomic data to drive drug repurposing for various diseases<br>Lalu Muhammad Irham<br>8. RNA therapeutics for glioma/glioblastoma<br>Amir R Afshari<br>9. RNA therapeutics for regenerative medicine<br>Dinh -Toi Chu<br>10. Advances in the liposome-based delivery systems for RNA therapeutics in cancer<br>Amir R Afshari<br>11. Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics in cancer<br>Prashant Kesharwani<br>12. Advances in RNA therapeutics for modulation of ´undruggable´ targets<br>Emily Martinsen and Marie Rogne<br>13. Biosafety and regulatory issues of RNA therapeutics<br>Dinh -Toi Chu